Global New Medical Materials and Biomaterials Market Analysis and Forecast 2024-2030

Global New Medical Materials and Biomaterials Market Analysis and Forecast 2024-2030


Summary

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

According to APO Research, The global New Medical Materials and Biomaterials market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for New Medical Materials and Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of New Medical Materials and Biomaterials include STR, Avitus, Sagemax, Stratasys, Formlab, NanoH2O (LG), Covalent-coating, Nasseo and TriboFilm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for New Medical Materials and Biomaterials, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of New Medical Materials and Biomaterials, also provides the revenue of main regions and countries. Of the upcoming market potential for New Medical Materials and Biomaterials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the New Medical Materials and Biomaterials revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global New Medical Materials and Biomaterials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for New Medical Materials and Biomaterials revenue, projected growth trends, production technology, application and end-user industry.

New Medical Materials and Biomaterials segment by Company

STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
New Medical Materials and Biomaterials segment by Type

Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
New Medical Materials and Biomaterials segment by Application

Packaging
Transplant Components
Dental Products
Catheters
Others
New Medical Materials and Biomaterials segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of New Medical Materials and Biomaterials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of New Medical Materials and Biomaterials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Medical Materials and Biomaterials revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 New Medical Materials and Biomaterials Market by Type
1.2.1 Global New Medical Materials and Biomaterials Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Medical Polymers
1.2.3 Bioceramics
1.2.4 Medical 3D Printing Materials
1.2.5 Membranes
1.2.6 Surface Modifications
1.2.7 Others
1.3 New Medical Materials and Biomaterials Market by Application
1.3.1 Global New Medical Materials and Biomaterials Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Packaging
1.3.3 Transplant Components
1.3.4 Dental Products
1.3.5 Catheters
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 New Medical Materials and Biomaterials Market Dynamics
2.1 New Medical Materials and Biomaterials Industry Trends
2.2 New Medical Materials and Biomaterials Industry Drivers
2.3 New Medical Materials and Biomaterials Industry Opportunities and Challenges
2.4 New Medical Materials and Biomaterials Industry Restraints
3 Global Growth Perspective
3.1 Global New Medical Materials and Biomaterials Market Perspective (2019-2030)
3.2 Global New Medical Materials and Biomaterials Growth Trends by Region
3.2.1 Global New Medical Materials and Biomaterials Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global New Medical Materials and Biomaterials Market Size by Region (2019-2024)
3.2.3 Global New Medical Materials and Biomaterials Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global New Medical Materials and Biomaterials Revenue by Players
4.1.1 Global New Medical Materials and Biomaterials Revenue by Players (2019-2024)
4.1.2 Global New Medical Materials and Biomaterials Revenue Market Share by Players (2019-2024)
4.1.3 Global New Medical Materials and Biomaterials Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global New Medical Materials and Biomaterials Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global New Medical Materials and Biomaterials Key Players Headquarters & Area Served
4.4 Global New Medical Materials and Biomaterials Players, Product Type & Application
4.5 Global New Medical Materials and Biomaterials Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global New Medical Materials and Biomaterials Market CR5 and HHI
4.6.2 Global Top 5 and 10 New Medical Materials and Biomaterials Players Market Share by Revenue in 2023
4.6.3 2023 New Medical Materials and Biomaterials Tier 1, Tier 2, and Tier 3
5 New Medical Materials and Biomaterials Market Size by Type
5.1 Global New Medical Materials and Biomaterials Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global New Medical Materials and Biomaterials Revenue by Type (2019-2030)
5.3 Global New Medical Materials and Biomaterials Revenue Market Share by Type (2019-2030)
6 New Medical Materials and Biomaterials Market Size by Application
6.1 Global New Medical Materials and Biomaterials Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global New Medical Materials and Biomaterials Revenue by Application (2019-2030)
6.3 Global New Medical Materials and Biomaterials Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 STR
7.1.1 STR Comapny Information
7.1.2 STR Business Overview
7.1.3 STR New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.1.4 STR New Medical Materials and Biomaterials Product Portfolio
7.1.5 STR Recent Developments
7.2 Avitus
7.2.1 Avitus Comapny Information
7.2.2 Avitus Business Overview
7.2.3 Avitus New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
7.2.5 Avitus Recent Developments
7.3 Sagemax
7.3.1 Sagemax Comapny Information
7.3.2 Sagemax Business Overview
7.3.3 Sagemax New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
7.3.5 Sagemax Recent Developments
7.4 Stratasys
7.4.1 Stratasys Comapny Information
7.4.2 Stratasys Business Overview
7.4.3 Stratasys New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
7.4.5 Stratasys Recent Developments
7.5 Formlab
7.5.1 Formlab Comapny Information
7.5.2 Formlab Business Overview
7.5.3 Formlab New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
7.5.5 Formlab Recent Developments
7.6 NanoH2O (LG)
7.6.1 NanoH2O (LG) Comapny Information
7.6.2 NanoH2O (LG) Business Overview
7.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
7.6.5 NanoH2O (LG) Recent Developments
7.7 Covalent-coating
7.7.1 Covalent-coating Comapny Information
7.7.2 Covalent-coating Business Overview
7.7.3 Covalent-coating New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
7.7.5 Covalent-coating Recent Developments
7.8 Nasseo
7.8.1 Nasseo Comapny Information
7.8.2 Nasseo Business Overview
7.8.3 Nasseo New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
7.8.5 Nasseo Recent Developments
7.9 TriboFilm
7.9.1 TriboFilm Comapny Information
7.9.2 TriboFilm Business Overview
7.9.3 TriboFilm New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
7.9.5 TriboFilm Recent Developments
7.10 ACS material
7.10.1 ACS material Comapny Information
7.10.2 ACS material Business Overview
7.10.3 ACS material New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
7.10.5 ACS material Recent Developments
7.11 Palmaz Scientific
7.11.1 Palmaz Scientific Comapny Information
7.11.2 Palmaz Scientific Business Overview
7.11.3 Palmaz Scientific New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
7.11.5 Palmaz Scientific Recent Developments
7.12 Invibio
7.12.1 Invibio Comapny Information
7.12.2 Invibio Business Overview
7.12.3 Invibio New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
7.12.5 Invibio Recent Developments
7.13 Secant Medical
7.13.1 Secant Medical Comapny Information
7.13.2 Secant Medical Business Overview
7.13.3 Secant Medical New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
7.13.5 Secant Medical Recent Developments
7.14 TeraPore Technologies
7.14.1 TeraPore Technologies Comapny Information
7.14.2 TeraPore Technologies Business Overview
7.14.3 TeraPore Technologies New Medical Materials and Biomaterials Revenue and Gross Margin (2019-2024)
7.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
7.14.5 TeraPore Technologies Recent Developments
8 North America
8.1 North America New Medical Materials and Biomaterials Revenue (2019-2030)
8.2 North America New Medical Materials and Biomaterials Revenue by Type (2019-2030)
8.2.1 North America New Medical Materials and Biomaterials Revenue by Type (2019-2024)
8.2.2 North America New Medical Materials and Biomaterials Revenue by Type (2025-2030)
8.3 North America New Medical Materials and Biomaterials Revenue Share by Type (2019-2030)
8.4 North America New Medical Materials and Biomaterials Revenue by Application (2019-2030)
8.4.1 North America New Medical Materials and Biomaterials Revenue by Application (2019-2024)
8.4.2 North America New Medical Materials and Biomaterials Revenue by Application (2025-2030)
8.5 North America New Medical Materials and Biomaterials Revenue Share by Application (2019-2030)
8.6 North America New Medical Materials and Biomaterials Revenue by Country
8.6.1 North America New Medical Materials and Biomaterials Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America New Medical Materials and Biomaterials Revenue by Country (2019-2024)
8.6.3 North America New Medical Materials and Biomaterials Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe New Medical Materials and Biomaterials Revenue (2019-2030)
9.2 Europe New Medical Materials and Biomaterials Revenue by Type (2019-2030)
9.2.1 Europe New Medical Materials and Biomaterials Revenue by Type (2019-2024)
9.2.2 Europe New Medical Materials and Biomaterials Revenue by Type (2025-2030)
9.3 Europe New Medical Materials and Biomaterials Revenue Share by Type (2019-2030)
9.4 Europe New Medical Materials and Biomaterials Revenue by Application (2019-2030)
9.4.1 Europe New Medical Materials and Biomaterials Revenue by Application (2019-2024)
9.4.2 Europe New Medical Materials and Biomaterials Revenue by Application (2025-2030)
9.5 Europe New Medical Materials and Biomaterials Revenue Share by Application (2019-2030)
9.6 Europe New Medical Materials and Biomaterials Revenue by Country
9.6.1 Europe New Medical Materials and Biomaterials Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe New Medical Materials and Biomaterials Revenue by Country (2019-2024)
9.6.3 Europe New Medical Materials and Biomaterials Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China New Medical Materials and Biomaterials Revenue (2019-2030)
10.2 China New Medical Materials and Biomaterials Revenue by Type (2019-2030)
10.2.1 China New Medical Materials and Biomaterials Revenue by Type (2019-2024)
10.2.2 China New Medical Materials and Biomaterials Revenue by Type (2025-2030)
10.3 China New Medical Materials and Biomaterials Revenue Share by Type (2019-2030)
10.4 China New Medical Materials and Biomaterials Revenue by Application (2019-2030)
10.4.1 China New Medical Materials and Biomaterials Revenue by Application (2019-2024)
10.4.2 China New Medical Materials and Biomaterials Revenue by Application (2025-2030)
10.5 China New Medical Materials and Biomaterials Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia New Medical Materials and Biomaterials Revenue (2019-2030)
11.2 Asia New Medical Materials and Biomaterials Revenue by Type (2019-2030)
11.2.1 Asia New Medical Materials and Biomaterials Revenue by Type (2019-2024)
11.2.2 Asia New Medical Materials and Biomaterials Revenue by Type (2025-2030)
11.3 Asia New Medical Materials and Biomaterials Revenue Share by Type (2019-2030)
11.4 Asia New Medical Materials and Biomaterials Revenue by Application (2019-2030)
11.4.1 Asia New Medical Materials and Biomaterials Revenue by Application (2019-2024)
11.4.2 Asia New Medical Materials and Biomaterials Revenue by Application (2025-2030)
11.5 Asia New Medical Materials and Biomaterials Revenue Share by Application (2019-2030)
11.6 Asia New Medical Materials and Biomaterials Revenue by Country
11.6.1 Asia New Medical Materials and Biomaterials Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia New Medical Materials and Biomaterials Revenue by Country (2019-2024)
11.6.3 Asia New Medical Materials and Biomaterials Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA New Medical Materials and Biomaterials Revenue (2019-2030)
12.2 MEALA New Medical Materials and Biomaterials Revenue by Type (2019-2030)
12.2.1 MEALA New Medical Materials and Biomaterials Revenue by Type (2019-2024)
12.2.2 MEALA New Medical Materials and Biomaterials Revenue by Type (2025-2030)
12.3 MEALA New Medical Materials and Biomaterials Revenue Share by Type (2019-2030)
12.4 MEALA New Medical Materials and Biomaterials Revenue by Application (2019-2030)
12.4.1 MEALA New Medical Materials and Biomaterials Revenue by Application (2019-2024)
12.4.2 MEALA New Medical Materials and Biomaterials Revenue by Application (2025-2030)
12.5 MEALA New Medical Materials and Biomaterials Revenue Share by Application (2019-2030)
12.6 MEALA New Medical Materials and Biomaterials Revenue by Country
12.6.1 MEALA New Medical Materials and Biomaterials Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA New Medical Materials and Biomaterials Revenue by Country (2019-2024)
12.6.3 MEALA New Medical Materials and Biomaterials Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings